SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont (NEM) is trending due to mixed reactions to its recent earnings, with some investors citing a double beat and bullish gold forecasts, while others point to weak cash flow and increased debt. Community members are debating the significance of the earnings release and the new CEO's performance, alongside gold price movements. Technical analysts are also weighing in, noting a potential Elliott Wave breakout.

$BALLIN is the perfect meme for everyone showing up every single day.  To be BALLIN, you gotta B-All-In.  The meaning to B All In doesn't only apply to the funds you invest.  It's about dedication.   The countless hours of research.   The endless raiding and working for your bags.  Not knowing how to quit while everyone is telling you you're wrong.  It's about believing in something.  Keep $BALLIN

B All In

B All In (BALLIN) is trending as users promote the token and encourage others to buy, touting potential gains. Community members are highlighting its availability on Phantom Wallet and suggesting it embodies a luxurious lifestyle. However, some users are cautioning against the hype, labeling it a potential scam.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Grayscale Bitcoin Mini Trust ETF ($BTC) is trending amid Bitcoin's price volatility and discussions around potential market manipulation. Community members are debating future price targets, with some pointing to potential bullish catalysts and others expressing caution. Broader market themes, such as the relationship between Bitcoin and gold, are also influencing the conversation.

STMicroelectronics NV is a global semiconductor company, which engages in the business of designing, developing, manufacturing, and marketing products used in a wide variety of applications for automotive, industrial, personal electronics and communications equipment, computers, and peripherals. It operates through the following segments: Automotive and Discrete Group (ADG), Analog, MEMS, and Sensors Group (AMS), Microcontrollers and Digital ICs Group (MDG), and Others. The ADG segment includes dedicated automotive integrated circuits and discrete and power transistor products. The AMS segment offers analog, smart power, MEMS sensors and actuators, and optical sensing solutions. The MDG segment focuses on general-purpose microcontrollers and microprocessors, connected security products, memories, and RF and communications products. The Others segment is involved in sales assembly services and other revenues. The company was founded in June 1987 and is headquartered in Plan-Les-Ouates, Switzerland.

ST Microelectronics - New York Shares

STMicroelectronics NV

STM is trending as news circulates regarding potential alternative chip supplier negotiations with Volkswagen, sparking community interest due to STM's proximity to VW production. Additionally, the stock is seeing increased interest due to several recent announcements, including advancements in AI datacenter technology and photonics. The community is also following analyst price target updates and European consortium involvement in next-generation silicon photonics.

Avantis is the largest RWA perps DEX in DeFi, built on and backed by Base. Avantis allows users to trade crypto and real-world assets (RWAs), including FX, commodities, indices, and equities. Backed by Pantera and Coinbase, Avantis is the largest DEX on Base by volumes, and brings institutional-grade products to DeFi, letting users trade with up to 500x leverage in a transparent, permissionless environment.  Avantis is best known for launching zero-fee perpetuals (ZFP) — a first-of-its-kind primitive where traders only pay fees if they profit. They've also brought leveraged RWAs onchain. This has driven explosive growth: over $20B+ in cumulative volume and 15M+ run-rate revenues since Febrruary 2024.

Avantis

Avantis ($AVNT) is trending as the community discusses its potential, fueled by speculation of bullish momentum and a possible breakout.  Many traders are focused on short-term price targets, with some suggesting it is undervalued compared to similar projects.  The crypto's connection to Coinbase and its position within the Real World Asset (RWA) narrative are also key talking points.

Sigma bnb USD

BNBUSD is trending due to a noted 'Blue Box' technical pattern, signaling a potential buying opportunity and a strong reaction higher. The community is discussing the recent bounce from this zone and whether it could be the start of a more significant bullish move. Traders are watching for a break above key levels to confirm the next leg up.

Inhibrx Biosciences, Inc. is a clinical-stage biopharmaceutical company, which includes a pipeline of novel biologic therapeutic candidates, developed using proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize multivalent formats where the precise valency can be optimized in a target-centric way to mediate what is believed to be the most appropriate agonist function. The company was founded by Brendan P. Eckelman on January 8, 2024 and is headquartered in La Jolla, CA.

Inhibrx Biosciences Inc.

Inhibrx Inc

Inhibrx is trending after announcing the potential for accelerated FDA approval of INBRX-101, driving significant after-hours gains. The community is actively discussing potential price targets and whether the data justifies the surge, while some caution against a possible sell-the-news event or future offering. The stock is also appearing on top gainer lists alongside other high-momentum tickers.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power ($SMR) is trending as investors discuss the potential impact of increasing energy demand from AI and data centers, with some highlighting its advancements in small modular reactor (SMR) technology. Community members are also following news related to government initiatives in the nuclear sector and comparing $SMR's valuation and progress against peers. Additionally, some traders are noting technical indicators that suggest a possible breakout.

GE Vernova, Inc. is a electric power industry. Its products and services generate, transfer, orchestrate, convert, and store electricity. The firm operates through the following segments: Power, Wind and Electrification. The Power segment includes design, manufacture, and servicing of gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment includes wind generation technologies, inclusive of onshore and offshore wind turbines and blades. The Electrification segment includes grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The Company was founded November 09, 2021 and is headquartered in Cambridge, Massachusetts.

GE Vernova Inc.

GE Vernova ($GEV) is trending due to increased attention surrounding the surge in electricity demand for AI data centers, with the community actively discussing target price increases and the company's strategic positioning in the energy sector. Bullish sentiment is fueled by GE Vernova's potential to reach new all-time highs as a key player in the energy transition and AI infrastructure buildout. Some investors express caution about a possible pullback.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF ($TLT) is trending as investors weigh economic uncertainty and potential Federal Reserve actions amid a government shutdown. Community discussions revolve around the ETF's potential as a safe haven asset and its inverse relationship with bond yields, as well as the potential for a short squeeze. Some traders are closely monitoring volume and technical indicators for potential upside, while others remain cautious due to concerns about inflation and the broader economic outlook.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Scienture has commenced selling Arbli, the first FDA-approved ready-to-use liquid losartan formulation.</li><li>The U.S. losartan market is worth about $256 million annually, offering strong growth potential for Arbli.</li><li>Scienture secured key GPO agreements to expand Arbli’s availability to over 2,500 healthcare facilities nationwide.</li></ul>Scienture Holdings Inc. (SCNX) on Thursday announced the launch of commercial sales for its new product, Arbli (losartan potassium) Oral Suspension, 10 mg/mL.Arbli is the first FDA-approved, ready-to-use oral suspension of losartan potassium, offering patients who require alternatives to pills a safe and consistent treatment option.&nbsp;With the U.S. losartan market generating around $256 million annually and more than 71 million prescriptions written each year, according to IQVIA data, Scienture sees a strong potential for this new product.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Shares of Scienture Holdings surged by more than 122% by Thursday noon. On Stocktwits, retail sentiment around the stock remained in ‘extremely bullish’ territory amid ‘extremely high’ message volume levels.&nbsp;<figure class="image"><img style="aspect-ratio:938/107;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_23_114143_png_e27a7261e9.webp" alt="SCNX’s Sentiment Meter and Message Volume as of 11:25 a.m. ET on Oct. 23, 2025 | Source: Stocktwits" width="938" height="107"><figcaption>SCNX’s Sentiment Meter and Message Volume as of 11:25 a.m. ET on Oct. 23, 2025 | Source: Stocktwits</figcaption></figure>A bullish Stocktwits user said the company’s valuation might reach billions if the product is expanded globally.&nbsp;<stembedurl>https://stocktwits.com/jreddyN/message/633437362</stembedurl><h2 class="st-heading-2">Arbli’s Importance</h2>Arbli is a unique liquid form of losartan, a common medication for high blood pressure. It doesn’t need compounding, offers a smaller dosing volume, and has a long shelf life at room temperature. Arbli is approved to treat hypertension in patients over six years old, to lower stroke risk in those with hypertension and heart enlargement, and manage diabetic kidney disease in certain type 2 diabetes patients.To support Arbli’s market entry, Scienture has secured Pharmacy Benefit Manager-led Group Purchasing Organization (PBM-Led GPO) agreements to broaden commercial coverage and formulary inclusion. Scienture has also finalized contracts with multiple commercial GPOs, allowing Arbli to reach over 2,500 healthcare institutions nationwide.&nbsp;Scienture’s stock has lost over 79% in 2025 and over 82% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/datavault-ai-to-boost-growth-with-new-headquarters-quantum-centers/cLG4mQdR3rQ">Datavault AI To Boost Growth With New Headquarters, Quantum Centers</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Is Scienture Stock Rising Today?

Scienture has commenced selling Arbli, the first FDA-approved ready-to-use liquid losartan formulation.

Equity

Scienture Holdings, Inc. engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Commack, NY.

SCNX
Scienture Holdings Inc.

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest SCNX News

SCNXScienture Holdings Inc.